CSI Market
Sign In | Register

Myriad Genetics Inc (MYGN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MYGN Annual Cash Flow →
Quarterly cash flow trends provide additional context on Myriad Genetics Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-77.30
Depreciation & amortization34.50
Amortization of Other Assets15.70
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges9.90
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation13.70
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total0.00
Non Cash Interest Expense-
Costmethod Investments Other Than Temporary Impairment-
Increase Decrease In Unrecognized Tax Benefits-
Unrecognized Tax Benefits Period Increase Decrease-
Change In Fair Value Of Contingent Consideration-
Impairment Of Goodwill And Long Lived Assets Held For Use-
Goodwill And Intangible Asset Impairment-
Operating Lease Right Of Use Asset Amortization Expense1.00
Gain Loss On Termination Of Lease-
Asset Acquisition Gain Loss-
Income taxes0.00
Marketable Securities, Realized Gain (Loss), Excluding Other than Temporary Impairments, Total0.00
Increase (Decrease) in Accounts Receivable-5.70
Increase (Decrease) in Accounts Payable2.90
Increase (Decrease) in Accrued Liabilities-6.40
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-3.30
Other Working Capital0.30
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-8.30
Discontinued operations0.00
Net Cash flow from Operating Activities-24.00
Investing Activities
Capital Expenditures-9.70
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Proceeds from Divestiture of Interest in Consolidated Subsidiaries0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Accounts payable0.00
Receivables0.00
Payments to Acquire Projects0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-9.70
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.80
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-3.30
Other net-0.30
Proceeds From Repayments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options-
Change In Cash And Cash Equivalents Classified As Held For Sale-
Finance Lease Principal Payments-0.10
Payments For Release Of Escrow-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.80
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-33.70
Total Cash Flow-34.50
4 historic quarters locked

Sign in to unlock the full Myriad Genetics Inc cash flow history.

Sign In Create Free Account

About Myriad Genetics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000899923-26-000072

Figures are derived from filed reports and may be restated. Historical data is subject to revision.